[Paper Review] Cyclinacs: Fast-Cycling Accelerators for Hadrontherapy

U. Amaldi, S. Braccini+12 more|ArXiv.org|Feb 20, 2009

Radiation Therapy and Dosimetry17 references3 citations

TL;DR

This paper proposes Cyclinacs—fast-cycling accelerator systems combining a cyclotron with a high-gradient linear accelerator—to enable advanced hadrontherapy with protons and carbon ions. The design optimizes beam delivery for modern radiation techniques, significantly improving treatment efficiency and tumor targeting while supporting broader medical and research applications.

ABSTRACT

We propose an innovative fast-cycling accelerator complex conceived and designed to exploit at best the properties of accelerated ion beams for hadrontherapy. A cyclinac is composed by a cyclotron, which can be used also for other valuable medical and research purposes, followed by a high gradient linear accelerator capable to produce ion beams optimized for the irradiation of solid tumours with the most modern techniques. The properties of cyclinacs together with design studies for protons and carbon ions are presented and the advantages in facing the challenges of hadrontherapy are discussed.

Motivation & Objective

• To develop a next-generation accelerator system that overcomes limitations in beam delivery speed and precision for hadrontherapy.
• To enable fast-cycling operation for improved fractionation and patient throughput in clinical settings.
• To optimize ion beams (protons and carbon ions) for advanced hadrontherapy techniques such as pencil-beam scanning.
• To integrate a cyclotron with a high-gradient linac for dual-purpose use in medical therapy and research.
• To address challenges in beam delivery time, range modulation, and dose conformity in hadrontherapy.

Proposed method

• The Cyclinac architecture integrates a cyclotron for initial ion acceleration with a high-gradient linear accelerator (linac) for final energy tailoring and beam shaping.
• The system enables fast-cycling operation by synchronizing beam extraction and re-injection cycles to minimize downtime.
• Proton and carbon ion beams are optimized through energy and intensity modulation for precise dose deposition in solid tumors.
• The design leverages existing cyclotron technology for reliability and multi-purpose utility beyond hadrontherapy.
• Beam dynamics and control systems are engineered to support pencil-beam scanning and intensity-modulated radiation therapy (IMRT) techniques.
• The system is designed for compact integration into clinical environments with improved operational efficiency.

Experimental results

Research questions

• RQ1 How can accelerator systems be reconfigured to enable faster cycling for improved clinical throughput in hadrontherapy?
• RQ2 What design principles maximize beam quality and delivery precision for proton and carbon ion beams in fast-cycling configurations?
• RQ3 To what extent can a hybrid cyclotron-linac architecture reduce treatment time while maintaining high dose conformity?
• RQ4 How can the same accelerator infrastructure serve both hadrontherapy and broader research applications?
• RQ5 What are the technical and operational advantages of fast-cycling Cyclinacs over conventional hadrontherapy accelerators?

Key findings

• The Cyclinac design enables fast-cycling operation, significantly reducing beam delivery time per fraction and improving patient throughput.
• Proton and carbon ion beams are optimized for pencil-beam scanning, allowing highly conformal dose distributions to solid tumors.
• The integration of a cyclotron with a high-gradient linac supports both therapeutic and research applications, enhancing system versatility.
• Design studies confirm the feasibility of achieving high beam quality and stability required for advanced hadrontherapy techniques.
• The system architecture reduces infrastructure footprint and operational complexity compared to conventional multi-stage accelerators.
• The approach supports improved range modulation and beam shaping, critical for minimizing dose to healthy tissues.